Symphony Asset Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-16,739
Closed -$336K 224
2018
Q3
$336K Sell
16,739
-1,085
-6% -$23K 0.09% 133
2018
Q2
$332K Sell
17,824
-26,958
-60% -$426K 0.07% 168
2018
Q1
$611K Buy
44,782
+8,449
+23% +$111K 0.08% 219
2017
Q4
$493K Buy
36,333
+6,186
+21% +$88.8K 0.05% 262
2017
Q3
$475K Sell
30,147
-1,979
-6% -$31.9K 0.05% 273
2017
Q2
$553K Buy
32,126
+8,333
+35% +$127K 0.06% 256
2017
Q1
$363K Buy
23,793
+7,492
+46% +$110K 0.03% 321
2016
Q4
$215K Buy
+16,301
New +$209K 0.02% 381

Other funds holding NXGN

Symphony Asset Management's NXGN Position: Q4 2018 in Review

Symphony Asset Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2018, closing a stake of 16,739 shares — an estimated $336K sold.

Symphony Asset Management first reported a position in NXGN in Q4 2016 and held it in 8 quarters. The position peaked at $611K in Q1 2018. 175 funds tracked by Wall St. Rank hold NXGN as of Q4 2018.

  • Symphony Asset Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Symphony Asset Management sold 16,739 NextGen Healthcare, Inc. Common Stock shares in Q4 2018, an estimated $336K.
  • Symphony Asset Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2016 and held it in 8 quarters.
  • Symphony Asset Management's NextGen Healthcare, Inc. Common Stock position peaked at $611K in Q1 2018.
  • 175 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2018.

Based on Symphony Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.